Stock HAE HAEMATO AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials HAEMATO AG Xetra

Equities

HAE

DE000A289VU3

Pharmaceuticals

End-of-day quote Xetra
Other stock markets
 06:00:00 2024-02-04 pm EST 		5-day change 1st Jan Change
26.2 EUR -0.76% Intraday chart for HAEMATO AG -1.50% -5.76%
2021 HAEMATO AG Proposes Dividend Payment CI
2021 HAEMATO AG Provides Earnings Guidance for the Year 2021 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 102.2 67.18 52.55 124.9 89.91 111.9 111.9 -
Enterprise Value (EV) 1 102.2 67.18 60.72 109.7 67.37 90.57 87.57 83.37
P/E ratio 17.2 x -58.8 x -22.5 x 17.7 x 11 x 14.3 x 11.8 x 10.7 x
Yield - - 4.35% 4.6% 6.98% 5.05% 5.37% 5.93%
Capitalization / Revenue 0.37 x 0.34 x 0.22 x 0.44 x 0.36 x 0.41 x 0.4 x 0.38 x
EV / Revenue 0.37 x 0.34 x 0.25 x 0.38 x 0.27 x 0.34 x 0.31 x 0.28 x
EV / EBITDA 10.3 x - 18.3 x 8.68 x 6.97 x 6.95 x 6.08 x 5.11 x
EV / FCF - - 4.39 x 7.9 x 3.93 x 20.9 x 10.9 x 10 x
FCF Yield - - 22.8% 12.7% 25.4% 4.78% 9.14% 9.96%
Price to Book - - - 0.86 x 0.61 x 0.75 x 0.73 x 0.7 x
Nbr of stocks (in thousands) 2,198 2,285 2,285 5,228 5,228 5,228 5,228 -
Reference price 2 46.50 29.40 23.00 23.90 17.20 21.40 21.40 21.40
Announcement Date 5/8/19 4/30/20 5/26/21 5/17/22 5/8/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 274.1 197.8 238.3 285 248.1 269.7 281 295.7
EBITDA 1 9.959 - 3.315 12.64 9.661 13.03 14.4 16.3
EBIT 1 - - 1.627 11.16 8.295 11.51 12.86 14.6
Operating Margin - - 0.68% 3.92% 3.34% 4.27% 4.58% 4.94%
Earnings before Tax (EBT) 1 - - - 9.357 10.48 10.23 12.45 14
Net income 1 - - -4.831 6.862 8.193 7.809 9.467 10.41
Net margin - - -2.03% 2.41% 3.3% 2.9% 3.37% 3.52%
EPS 2 2.700 -0.5000 -1.020 1.350 1.570 1.497 1.810 1.995
Free Cash Flow 1 - - 13.83 13.88 17.12 4.331 8 8.3
FCF margin - - 5.8% 4.87% 6.9% 1.61% 2.85% 2.81%
FCF Conversion (EBITDA) - - 417.11% 109.86% 177.22% 33.23% 55.54% 50.9%
FCF Conversion (Net income) - - - 202.3% 208.98% 55.46% 84.5% 79.73%
Dividend per Share 2 - - 1.000 1.100 1.200 1.080 1.150 1.270
Announcement Date 5/8/19 4/30/20 5/26/21 5/17/22 5/8/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2023 Q1
Net sales 1 54.6 66.4 68.4
EBITDA - 2.8 -
EBIT 2 2.4 -
Operating Margin 3.66% 3.61% -
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Dividend per Share - - -
Announcement Date 5/23/22 8/17/22 -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - 8.17 - - - - -
Net Cash position 1 - - - 15.2 22.5 21.3 24.3 28.5
Leverage (Debt/EBITDA) - - 2.464 x - - - - -
Free Cash Flow 1 - - 13.8 13.9 17.1 4.33 8 8.3
ROE (net income / shareholders' equity) - - -4.89% 4.84% 5.61% 4.85% 6.1% 6.3%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 - - - 27.70 28.20 28.40 29.30 30.40
Cash Flow per Share - - - - - - - -
Capex 1 1.06 - 0.85 0.29 1.02 0.93 0.9 0.9
Capex / Sales 0.39% - 0.36% 0.1% 0.41% 0.34% 0.32% 0.3%
Announcement Date 5/8/19 4/30/20 5/26/21 5/17/22 5/8/23 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for HAEMATO AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
21.4 EUR
Average target price
33 EUR
Spread / Average Target
+54.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MERCK KGAA Stock Merck KGaA
+5.31% 70.44B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.97% 8.94B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-16.83% 4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+43.48% 4.5B
YUHAN CORPORATION Stock Yuhan Corporation
+3.20% 3.85B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-21.36% 2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-29.67% 2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+8.38% 1.96B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+3.90% 1.65B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HAEK Stock
  4. HAE Stock
  5. Financials HAEMATO AG